Report Publication Announcement • Mar 29, 2022
Report Publication Announcement
Open in ViewerOpens in native device viewer
Annual report for 2021 for Medistim ASA
(Oslo, 29th of March 2022) Medistim ASA (OSE: MEDI), a niche market leader within ultrasound technology with headquarter in Norway, that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces that the Annual Report for 2021 is approved and available.
About Medistim:
Medistim was established in 1984, and has a track record of profitable growth
over the past >15 years. The company is a pioneer within its segment, and
continues to invest in new product development. Medistim has wholly owned
subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark
and Norway, in addition to the about 50 distributors in Europe, Asia, Middle
East, Africa, Canada and South America. For more information, visit the Medistim
home page: www.Medistim.com
This information is disclosed under Norwegian law (Verdipapirhandelloven §5-12).
For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: [email protected]
CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.